Downregulation of microRNA-23a confers protection against myocardial ischemia/reperfusion injury by upregulating tissue factor pathway inhibitor 2 following luteolin pretreatment in rats

Chin Med J (Engl). 2023 Apr 5;136(7):866-867. doi: 10.1097/CM9.0000000000002389.

Authors

Yuanyuan Luo¹, Li Li², Lele Wang², Pingping Shang², Defeng Pan¹, Yang Liu², Tongda Xu¹, Dongye Li^{1

2}

Affiliations

¹ Department of Cardiology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu 221006, China.
² Institute of Cardiovascular Disease Research, Xuzhou Medical University, Xuzhou, Jiangsu 221002, China.

No abstract available

Publication types

Letter

MeSH terms

Animals
Apoptosis
Down-Regulation
Luteolin / metabolism
Luteolin / pharmacology
Luteolin / therapeutic use
MicroRNAs* / genetics
MicroRNAs* / metabolism
Myocardial Reperfusion Injury* / drug therapy
Myocardial Reperfusion Injury* / genetics
Myocardial Reperfusion Injury* / metabolism
Rats
Rats, Sprague-Dawley
Reperfusion Injury*

Substances

Luteolin
lipoprotein-associated coagulation inhibitor
MicroRNAs